PEMETREXED VERSUS PEMETREXED PLUS CARBOPLATIN IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS

被引：0
|
作者：
Tiseo, Marcello [1 ]
Ardizzoni, Andrea [1 ]
Boni, Luca [2 ]
Vincent, A. [3 ]
Buti, S.
Camerini, Andrea
Labianca, R. [4 ]
Genestreti, Giovenzio [5 ]
Zanelli, Francesca [6 ]
Ciuffreda, L. [7 ]
Di Costanzo, F. [8 ]
De Marinis, F. [9 ]
Crino, Lucio [10 ]
Santo, A. [11 ]
Pazzola, A. [12 ]
Barbieri, F. [13 ]
Zilembo, N. [14 ]
Colantonio, I. [15 ]
Tibaldi, C. [16 ]
Smit, Egbert F. [17 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Ist Toscano Tumori, Coordinamento Sperimentaz Clin 4Ctr, Genoa, Italy
[3] Natl Canc Inst, Amsterdam, Netherlands
[4] Osped Riuniti Bergamo, Bergamo, Italy
[5] Irst Meldola, Oncol, Melola, Italy
[6] Osped Reggio Emilia, Reggio Emilia, Italy
[7] Osped Molinette, Molinette, Italy
[8] Osped Careggi, Florence, Italy
[9] San Camillo Forlanini, Rome, Italy
[10] Osped Perugia, Perugia, Italy
[11] Osped Verona, Verona, Italy
[12] Osped Sassari, Sassari, Italy
[13] Policlin Modena, Modena, Italy
[14] Ist Nazl Tumori, Naples, Italy
[15] Osped Cuneo, Cuneo, Italy
[16] Osped Livorno, Livorno, Italy
[17] Vrije Univ, Med Ctr, Pulmonol Dept, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; second-line chemotherapy; Pemetrexed; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S415 / S415
页数：1
相关论文
共 50 条
  • [41] Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
    Zhang, Liang
    Ou, Wei
    Liu, Qianwen
    Li, Ning
    Liu, Li
    Wang, Siyu
    THORACIC CANCER, 2014, 5 (01) : 50 - 56
  • [42] Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study
    Karampeazis, Athanasios
    Voutsina, Alexandra
    Souglakos, John
    Kentepozidis, Nikos
    Giassas, Stelios
    Christofillakis, Charalambos
    Kotsakis, Athanasios
    Papakotoulas, Pavlos
    Rapti, Ageliki
    Agelidou, Maria
    Agelaki, Sofia
    Vamvakas, Lambros
    Samonis, George
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    CANCER, 2013, 119 (15) : 2754 - 2764
  • [43] Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Woo, Hyun Sun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Inkeun
    Sym, Sun Jin
    Kyung, Sun Young
    Kang, Shin Myung
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 80 - 87
  • [44] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer
    Dalsania, C. J.
    Hageboutros, A.
    Harris, E.
    Krieger, K.
    Vora, C.
    Stevenson, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [46] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Tanijiri, Tsutomu
    Ogata, Makoto
    Inagaki, Noriko
    Kibata, Kayoko
    Hayashi, Mina
    Niki, Maiko
    Shimizu, Toshiki
    Miyara, Takayuki
    Kurata, Takayasu
    Nomura, Shosaku
    ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
  • [47] Vitamin supplementation in patients receiving pemetrexed for advanced non-small cell lung cancer
    de Marinis, Filippo
    Passaro, Antonio
    Clarke, Stephen
    LUNG CANCER, 2013, 82 (03) : 511 - 511
  • [48] Efficacy of erlotinib in patients with advanced non-small cell lung cancer: a pooled analysis of randomized trials
    Gao, Hui
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Aziz, Fahad
    Wang, Daoyuan
    Zhang, Tao
    ANTI-CANCER DRUGS, 2011, 22 (09) : 842 - 852
  • [49] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya
    Akihiro Tamiya
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Kiyotaka Yoh
    Koichi Goto
    Hiroaki Okamoto
    Tsuneo Shimokawa
    Tetsuya Abe
    Hiroshi Tanaka
    Haruko Daga
    Koji Takeda
    Tomonori Hirashima
    Shinji Atagi
    Medical Oncology, 2016, 33
  • [50] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Yoh, Kiyotaka
    Goto, Koichi
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Abe, Tetsuya
    Tanaka, Hiroshi
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    MEDICAL ONCOLOGY, 2016, 33 (01) : 1 - 7
12345